Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

Fig. 1

a Distribution of plasma LL-37 concentrations in blood samples from culture positive patients with UTI compared to healthy controls participants. The patients have higher levels of plasma LL-37 than controls. b Distribution of urinary LL-37 concentrations after normalized to creatinine concentrations in urine samples from culture positive patients with UTI compared to healthy controls participants. The patients have higher levels of urinary LL-37 than controls

Back to article page